Buch, Englisch, 125 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 415 g
ISBN: 978-3-031-31796-5
Verlag: Springer Nature Switzerland
All currently known late effects for former childhood cancer patients are explored in detail: not only organ-related but also psychosocial related long-term sequelae. It closes the gap of missing detailed information and their consequences for individuals and society. Past, presence, and future of childhood cancer late effects is presented as well as models of care for childhood cancer survivors.
This book is essential for all professionals who work with childhood cancer survivors, no matter if oncologists, psychologists, social workers, or patient advocates. It is also a helpful textbook for university classrooms and seminars as well as for pediatric oncology fellowship programs.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Hämatologie, Transfusionsmedizin
- Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Pädiatrie, Neonatologie
Weitere Infos & Material
Part I: Beginnings and Basics.- 1 Past of Childhood Cancer.- 2 Incidence of Global Childhood Cancer.- 3 History of Childhood Cancer Late Effects.- Part II: Present of Childhood Cancer Late Effects.- 4 Organ-related Long-Term Consequences.- 5 Social and Psychosocial Late Effects.- 6 Economic and Other Fields of Late Effects.- Part III: Future of Childhood Cancer Late Effects.- 7 Global Childhood Cancer Survival.- 8 Surveillance for Late Effects.- 9 Reducing Methotrexate Induced Toxicity.- 10 Cognitive Recovery in Survivors of Pediatric Brain Tumors using Metformin.- 11 Treating Cancer Therapy-Related Cognitive Impairment.- 12 Contacting Former Patients.- 13 New Agents in Treatment.- 14 Cost-Effectiveness of Screenings for Survivors of Childhood Cancer.- 15 Models of Care for Long-term Survivors.